States agree to $7.4 billion settlement with Purdue Pharma in opioid litigation
All 50 states as well as Washington, D.C., and four U.S. territories have agreed to sign a $7.4 billion settlement with the company and once-prominent family behind OxyContin, officials announced Monday.
The settlement resolves pending litigation against Purdue Pharma, which, under the leadership of the Sackler families, invented, manufactured and aggressively marketed opioid products for decades, according to the lawsuits. States and cities across the country said it fueled waves of addiction and overdose deaths.
The attorneys general in 55 states and territories have signed on to the historic settlement, which they said will end the Sacklers' ownership of Purdue and bar them from making, selling or marketing opioids in the U.S.
MORE: Purdue Pharma, Sackler families boost contribution in opioid settlement to $7.4 billion
California, Colorado, Connecticut, Delaware, Florida, Illinois, Massachusetts, Oregon, Pennsylvania, Tennessee, Texas, Vermont, Virginia and West Virginia led the team that negotiated the settlement, which marks the largest of its kind involving the opioid crisis, officials said.
"As Pennsylvania families and communities suffered during an unprecedented addiction crisis, Purdue and the Sacklers reaped the mammoth profits from their products," Pennsylvania Attorney General Dave Sunday said in a statement. "This monumental settlement achieves the top priority of getting as much money as quickly as possible to prevention, treatment, and recovery programs across the Commonwealth. My office will continue engagement with municipal leaders to ensure millions of dollars reach every corner of the state."
Purdue introduced OxyContin, a brand name of oxycodone, in the 1990s and filed for Chapter 11 bankruptcy in 2019 after the company was sued thousands of times.
The U.S. Supreme Court overturned a prior settlement in June 2024 that would have awarded $6 billion to state and local governments.
The Sacklers and Purdue subsequently boosted their settlement contribution to $7.4 billion.
"Today's announcement of unanimous support among the states and territories is a critical milestone towards confirming a Plan of Reorganization that will provide billions of dollars to compensate victims, abate the opioid crisis, and deliver opioid use disorder and overdose rescue medicines that will save American lives," Purdue said in a statement on Monday. "We appreciate the extraordinarily hard work of the state attorneys general and our other creditors in getting us to this point, and we look forward to soliciting creditor votes on the Plan after the disclosure statement is approved."
The $7.4 billion will support opioid addiction treatment, prevention and recovery programs over the next 15 years.
A significant amount of the funds will be distributed in the first three years, with the Sacklers paying $1.5 billion and Purdue paying approximately $900 million in the first payment, followed by $500 million after one year, an additional $500 million after two years, and $400 million after three years.
MORE: Supreme Court blocks Purdue Pharma opioid settlement that shields Sackler family of liability
'There will never be enough justice, accountability or money to restore the families whose lives have been wrecked or to right the terrible consequences of the Sackler family's craven misconduct," Connecticut Attorney General William Tong said in a statement on Monday. "What we announce today is both momentous and insufficient, the culmination of years of tumultuous negotiations and legal battles all the way up to the U.S. Supreme Court."
Now that the state sign-on period has ended, local governments across the country will be asked to join the settlement, contingent on bankruptcy court approval. A hearing on that matter is scheduled on Wednesday.
A board of trustees selected by participating states in consultation with other creditors will determine the future of Purdue, which will continue to be overseen by a monitor and will be prevented from lobbying or marketing opioids.
ABC News' Aaron Katersky contributed to this report.
States agree to $7.4 billion settlement with Purdue Pharma in opioid litigation originally appeared on abcnews.go.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
22 minutes ago
- Bloomberg
Stock Movers: Circle, Kroger, Nvidia
On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Scarlet Fu, Alix Steel, Carol Massar and Tim Stenovec. - Circle (CRCL) shares soared after Seaport Global gave the stablecoin issuer its first buy rating in the wake of the US Senate's move this week to pass legislation setting up regulatory rules for cryptocurrencies pegged to the dollar. The company behind USDC, the second-largest stablecoin by market share, has seen its shares rise more than 600% since they started trading earlier this month. Optimism around stablecoin regulations has driven the strength. Seaport analyst Jeff Cantwell sees the global stablecoin market having the potential to reach $2 trillion at some point, from about $260 billion now. That would translate into annual revenue growth of 25%-30% for Circle, he wrote in a note to clients Friday. - Kroger (KR) shares were higher after its sales surpassed expectations during the latest quarter, a sign that consumers are still spending on groceries and other essentials despite economic turbulence. The nation's largest supermarket operator said its comparable sales, excluding fuel, rose 3.2% — better than what Wall Street analysts were expecting. The company also raised its full-year sales guidance to a range of 2.25% to 3.25%. It reaffirmed the rest of its outlook. Chief Financial Officer David Kennerley told analysts on the company's conference call that Kroger has seen an improvement in grocery volumes in recent quarters, which contributed to growth in the latest quarter. Kroger expects further volume expansion over the rest of 2025. Interim Chief Executive Officer Ronald Sargent said he's optimistic about the rest of the year while citing broader economic uncertainty. - Nvidia (NVDA) shares slumped, along with shares throughout the chip sector on the Wall Street Journal's reporting that a top US official told chipmakers that it's possible waivers they've used to access American technology in China could end up revoked.
Yahoo
an hour ago
- Yahoo
Kraken relocates US headquarters to Wyoming's crypto-friendly city
Kraken relocates US headquarters to Wyoming's crypto-friendly city originally appeared on TheStreet. Cryptocurrency exchange Kraken has officially moved its U.S. headquarters to Wyoming. The decision was primarily based on Wyoming's strong and future-oriented regulatory environment. This move is a significant endorsement of Wyoming's crypto-friendly regulatory landscape, which encompasses over 30 laws specifically tailored to the cryptocurrency sector, as per the company's blog. "Wyoming has built the country's most comprehensive and technically coherent legal framework for digital assets," Kraken co-CEO Arjun Sethi said in a statement. "Our global headquarters is now officially in Cheyenne, affirming our commitment to U.S.-based crypto innovation," he added. Wyoming has been at the forefront of regulating digital assets, with legislation that treats crypto as property, establishes a fintech sandbox for testing, and protects users from disclosing their private keys. Join the discussion with WendyO on Roundtable. Kraken has been involved with the state since at least 2021, when it gave a $300,000 grant to the University of Wyoming for crypto education. The company continued to promote cryptocurrency in the state by sponsoring the Wyoming Blockchain Stampede and co-hosting the state's first-ever Blockchain Symposium last year in Jackson Hole. Senator Cynthia Lummis, a long-time advocate for Bitcoin and digital asset policy, said she was excited about the development. "Kraken's decision to move to the Equality State underscores Wyoming's innovative approach," Lummis said. Kraken stated that, while it remains a globally distributed and remote-first company, the company's deeper physical presence in Wyoming reflects the favorable policy environment the state is creating, as well as the pro-crypto leadership from the state. This also further positions Wyoming as the de facto capital of American crypto regulation. Kraken relocates US headquarters to Wyoming's crypto-friendly city first appeared on TheStreet on Jun 20, 2025 This story was originally reported by TheStreet on Jun 20, 2025, where it first appeared. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Darden (NYSE:DRI) Reports Q2 In Line With Expectations
Restaurant company Darden (NYSE:DRI) met Wall Street's revenue expectations in Q2 CY2025, with sales up 10.6% year on year to $3.27 billion. Its GAAP profit of $2.58 per share was 12.1% below analysts' consensus estimates. Is now the time to buy Darden? Find out in our full research report. Revenue: $3.27 billion vs analyst estimates of $3.26 billion (10.6% year-on-year growth, in line) EPS (GAAP): $2.58 vs analyst expectations of $2.94 (12.1% miss) EPS (GAAP) guidance for the upcoming financial year 2026 is $10.60 at the midpoint, missing analyst estimates by 1.2% Operating Margin: 11.7%, down from 13.4% in the same quarter last year Free Cash Flow Margin: 8.4%, down from 9.7% in the same quarter last year Locations: 2,159 at quarter end, up from 2,031 in the same quarter last year Same-Store Sales rose 4.6% year on year (0% in the same quarter last year) Market Capitalization: $26.07 billion "We had a strong quarter with same-restaurant sales and earnings growth that exceeded our expectations," said Darden President & CEO Rick Cardenas. Founded in 1968 as Red Lobster, Darden (NYSE:DRI) is a leading American restaurant company that owns and operates a portfolio of popular restaurant brands. Examining a company's long-term performance can provide clues about its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. With $12.08 billion in revenue over the past 12 months, Darden is one of the most widely recognized restaurant chains and benefits from customer loyalty, a luxury many don't have. Its scale also gives it negotiating leverage with suppliers, enabling it to source its ingredients at a lower cost. However, its scale is a double-edged sword because there is only so much real estate to build restaurants, placing a ceiling on its growth. For Darden to boost its sales, it likely needs to adjust its prices, launch new chains, or lean into foreign markets. As you can see below, Darden's sales grew at a mediocre 6% compounded annual growth rate over the last six years (we compare to 2019 to normalize for COVID-19 impacts) as it barely increased sales at existing, established dining locations. This quarter, Darden's year-on-year revenue growth was 10.6%, and its $3.27 billion of revenue was in line with Wall Street's estimates. Looking ahead, sell-side analysts expect revenue to grow 8.7% over the next 12 months, an acceleration versus the last six years. This projection is above average for the sector and indicates its newer menu offerings will catalyze better top-line performance. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Darden sported 2,159 locations in the latest quarter. Over the last two years, it has opened new restaurants at a rapid clip by averaging 6.1% annual growth, among the fastest in the restaurant sector. When a chain opens new restaurants, it usually means it's investing for growth because there's healthy demand for its meals and there are markets where its concepts have few or no locations. The change in a company's restaurant base only tells one side of the story. The other is the performance of its existing locations, which informs management teams whether they should expand or downsize their physical footprints. Same-store sales is an industry measure of whether revenue is growing at those existing restaurants and is driven by customer visits (often called traffic) and the average spending per customer (ticket). Darden's demand within its existing dining locations has been relatively stable over the last two years but was below most restaurant chains. On average, the company's same-store sales have grown by 1.7% per year. This performance suggests it should consider improving its foot traffic and efficiency before expanding its restaurant base. In the latest quarter, Darden's same-store sales rose 4.6% year on year. This growth was an acceleration from its historical levels, which is always an encouraging sign. We enjoyed seeing Darden beat analysts' same-store sales expectations this quarter. We were also happy its revenue was in line with Wall Street's estimates. On the other hand, its EPS fell short of Wall Street's estimates. Looking ahead, EPS guidance also came in below expectations. Overall, this was a weaker quarter. The stock remained flat at $221 immediately following the results. Darden didn't show it's best hand this quarter, but does that create an opportunity to buy the stock right now? The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here, it's free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
